Through comprehensive assessments and open communication, well track the impact of the injections on your weight loss journey
Evidence and Clinical Guidance GLP-1 receptor agonists, primarily prescribed for type 2 diabetes and weight management, have demonstrated modest but consistent improvements in cholesterol and lipid profiles
While this supports immune cell activation and enhances pathogen clearance, excessive activation may contribute to tissue injury and immunosuppression (52)
- BPC-157 + GLP-1 agonists: BPC-157 may provide GI protection against GLP-1 side effects, but monitor closely as both affect gastric motility
Orders placed during this time will be dispatched on 30 July
The genetic context Wegovy prescribing overlooks Branded or compounded, a semaglutide prescription does not account for your genetic starting point